The director of our Mobile Stroke Treatment Unit reflects on lessons from our first six years of experience, along with what’s on the horizon in mobile stroke care.
Mobile stroke units can avert costs in delivery of acute stroke care once optimal thresholds are reached, a cost-consequence analysis finds. Avoidance of secondary interhospital transfers account for substantial potential savings.
An expert attendee draws from a wealth of presentations to share why a handful of new (and old) studies are likely to change practice in stroke care.
The first worldwide organization dedicated to mobile treatment of acute stroke has just elected its board of directors. One of those directors, Dr. Shazam Hussain, explains the group’s unique mission.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Mobile stroke units have been shown to accelerate patient evaluation and treatment. Now, for the first time, this speedier management has been shown to translate to clinical benefit for patients.
Mobile stroke units are gaining significant traction in the U.S. and around the world. A new paper looks back on the units’ time-to-treatment effects — and ahead to outcome and cost impacts.
A study on Cleveland Clinic’s mobile stroke unit reveals one characteristic that seems to particularly drive early IV thrombolysis delivery.
Practice may not make perfect in healthcare, but it can sure make for greater efficiency and effectiveness. This study of our mobile stroke unit’s evolution over three years is a case in point.
A Cleveland Clinic study presented at the 2018 International Stroke Conference suggests these units may help bypass interhospital transfers for patients requiring thrombectomy.
A report of Cleveland Clinic’s early experience with its mobile stroke unit shows it boosted the likelihood that patients who need tPA will get it in the recommended time window.